Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poxviruses as expression vectors

M W Carroll1, B Moss

  • 1Oxford BioMedica (UK) Ltd, Medawar Centre.

Current Opinion in Biotechnology
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Poxviruses offer advanced cytoplasmic gene expression in mammalian cells, with improved vectors enabling high, multi-gene integration. Safer, abortive infection poxviruses are highlighted for reduced cell damage and enhanced genetic engineering applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of the monkeypox virus genome.

Virology·2002
Same author

Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.

Cancer research·2001
Same author

Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Human monkeypox and smallpox viruses: genomic comparison.

FEBS letters·2001
Same author

High-speed mass transit for poxviruses on microtubules.

Nature cell biology·2001
Same author

Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails.

Journal of virology·2001
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Area of Science:

  • Molecular Biology
  • Virology
  • Genetic Engineering

Background:

  • Poxviruses are established tools for cytoplasmic expression of recombinant genes in mammalian cells.
  • Recent advancements have enhanced expression levels and facilitated the integration of multiple foreign genes.

Purpose of the Study:

  • To review recent improvements in poxvirus vectors for recombinant gene expression.
  • To highlight the potential of abortive infection poxviruses for safer gene delivery.
  • To discuss novel vector designs incorporating bacteriophage T7 RNA polymerase.

Main Methods:

  • Review of recent literature on poxvirus vector development.
  • Analysis of engineered poxvirus mutants with abortive infection properties.
  • Description of new replicating and non-replicating vectors.

Related Experiment Videos

Main Results:

  • Poxvirus vectors now support high-level expression and simplified multi-gene integration.
  • Abortive infection poxviruses demonstrate reduced cytopathic effects and increased safety.
  • Novel vectors encoding bacteriophage T7 RNA polymerase have been engineered for enhanced transcription.

Conclusions:

  • Poxvirus vectors continue to evolve as powerful tools for mammalian gene expression.
  • Safer poxvirus variants offer promising alternatives for gene therapy and biotechnology.
  • Engineered vectors provide versatile platforms for diverse recombinant gene applications.